Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
To overcome ICB resistance, combinations of decitabine or azacitidine with pembrolizumab are being tested in refractory Hodgkins lymphoma and solid tumors (NCT05355051, NCT03445858)
(2024) 25:e13762
Lets dive into what we know about GLP-1 medications and how they fit into long-term weight management
Still, 10,000 people is a tiny fraction of the number who try and fail to lose weight and keep it off long-term
Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways
US$ 22.72
US$ 27.34
US$ 20.72
US$ 25.74
US$ 28.22
US$ 23.29
US$ 23.22
